{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:30:53Z","timestamp":1769513453525,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502704"],"award-info":[{"award-number":["RF20200502704"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502704"],"award-info":[{"award-number":["RF20200502704"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502709"],"award-info":[{"award-number":["RF20200502709"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502704"],"award-info":[{"award-number":["RF20200502704"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502709"],"award-info":[{"award-number":["RF20200502709"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["DED-Line"],"award-info":[{"award-number":["DED-Line"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["DED-Line"],"award-info":[{"award-number":["DED-Line"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-03059-8","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:52:52Z","timestamp":1734634372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The F508del-CFTR trafficking correctors elexacaftor and tezacaftor are CFTR-independent Ca2+-mobilizing agonists normalizing abnormal Ca2+ levels in human airway epithelial cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Manuella","family":"L\u00e9v\u00eaque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Mirval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Barrault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Fixe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Coraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Sage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Becq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Vandebrouck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"3059_CR1","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1056\/NEJMra043184","volume":"352","author":"SM Rowe","year":"2005","unstructured":"Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352:1992\u20132001.","journal-title":"N Engl J Med"},{"key":"3059_CR2","unstructured":"Cystic Fibrosis Mutation Database. [cited 2023 Apr 1]. http:\/\/www.genet.sickkids.on.ca\/"},{"key":"3059_CR3","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2021 Annual Data Report. 2022."},{"key":"3059_CR4","unstructured":"Orenti A, Zolin A, Jung A, van Rens J et al. ECFS Patient Registry Annual Report 2020. 2022."},{"key":"3059_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","volume":"63","author":"SH Cheng","year":"1990","unstructured":"Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990;63:827\u201334.","journal-title":"Cell"},{"key":"3059_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1083\/jcb.118.3.551","volume":"118","author":"GM Denning","year":"1992","unstructured":"Denning GM, Ostedgaard LS, Welsh MJ. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol. 1992;118:551\u20139.","journal-title":"J Cell Biol"},{"key":"3059_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","volume":"73","author":"MJ Welsh","year":"1993","unstructured":"Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251\u20134.","journal-title":"Cell"},{"key":"3059_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/354526a0","volume":"354","author":"W Dalemans","year":"1991","unstructured":"Dalemans W, Barbry P, Champigny G, Jallat S, Jallat S, Dott K, et al. Altered chloride ion channel kinetics associated with the \u2206F508 cystic fibrosis mutation. Nature. 1991;354:526\u20138.","journal-title":"Nature"},{"key":"3059_CR9","doi-asserted-by":"publisher","first-page":"21592","DOI":"10.1016\/S0021-9258(20)80582-1","volume":"268","author":"GL Lukacs","year":"1993","unstructured":"Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, et al. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem. 1993;268:21592\u20138.","journal-title":"J Biol Chem"},{"key":"3059_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1191542","volume":"329","author":"T Okiyoneda","year":"2010","unstructured":"Okiyoneda T, Barri\u00e8re H, Bagd\u00e1ny M, Rabeh WM, Du K, H\u00f6hfeld J, et al. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science. 2010;329:805\u201310.","journal-title":"Science"},{"key":"3059_CR11","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1021\/bi501007v","volume":"53","author":"X Liu","year":"2014","unstructured":"Liu X, Dawson DC. Cystic fibrosis transmembrane Conductance Regulator (CFTR) potentiators protect G551D but not \u2206F508 CFTR from Thermal instability. Biochemistry. 2014;53:5613\u20138.","journal-title":"Biochemistry"},{"key":"3059_CR12","doi-asserted-by":"publisher","first-page":"41937","DOI":"10.1074\/jbc.M111.296061","volume":"286","author":"W Wang","year":"2011","unstructured":"Wang W, Okeyo GO, Tao B, Hong JS, Kirk KL. Thermally unstable gating of the most common cystic fibrosis Mutant Channel (\u2206F508). J Biol Chem. 2011;286:41937\u201348.","journal-title":"J Biol Chem"},{"key":"3059_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell. 2016;27:424\u201333.","journal-title":"Mol Biol Cell"},{"key":"3059_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nchembio.1253","volume":"9","author":"T Okiyoneda","year":"2013","unstructured":"Okiyoneda T, Veit G, Dekkers JF, Bagdany M, Soya N, Xu H, et al. Mechanism-based corrector combination restores \u2206F508-CFTR folding and function. Nat Chem Biol. 2013;9:444\u201354.","journal-title":"Nat Chem Biol"},{"key":"3059_CR15","doi-asserted-by":"crossref","unstructured":"Veit G, Roldan A, Hancock MA, Fonte DFD, Xu H, Hussein M et al. Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination. JCI Insight. 2020 [cited 2023 Apr 1];5. https:\/\/insight.jci.org\/articles\/view\/139983","DOI":"10.1172\/jci.insight.139983"},{"key":"3059_CR16","doi-asserted-by":"crossref","unstructured":"Laselva O, Bartlett C, Gunawardena TNA, Ouyang H, Eckford PDW, Moraes TJ et al. Rescue of multiple class II CFTR mutations by elexacaftor\u2009+\u2009tezacaftor\u2009+\u2009ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator. European Respiratory Journal. 2021 [cited 2023 Apr 1];57. https:\/\/erj.ersjournals.com\/content\/57\/6\/2002774","DOI":"10.1183\/13993003.02774-2020"},{"key":"3059_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jcf.2024.02.006","volume":"23","author":"H Bihler","year":"2024","unstructured":"Bihler H, Sivachenko A, Millen L, Bhatt P, Patel AT, Chin J, et al. In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis. J Cyst Fibros. 2024;23:664\u201375.","journal-title":"J Cyst Fibros"},{"key":"3059_CR18","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.3390\/ijerph19106114","volume":"19","author":"SA Aspinall","year":"2022","unstructured":"Aspinall SA, Mackintosh KA, Hill DM, Cope B, McNarry MA. Evaluating the Effect of Kaftrio on perspectives of Health and Wellbeing in individuals with cystic fibrosis. Int J Environ Res Public Health. 2022;19:6114.","journal-title":"Int J Environ Res Public Health"},{"key":"3059_CR19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.cellsig.2005.06.004","volume":"18","author":"O Tabary","year":"2006","unstructured":"Tabary O, Boncoeur E, de Martin R, Pepperkok R, Cl\u00e9ment A, Schultz C, et al. Calcium-dependent regulation of NF-\u03baB activation in cystic fibrosis airway epithelial cells. Cell Signal. 2006;18:652\u201360.","journal-title":"Cell Signal"},{"key":"3059_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ceca.2007.05.002","volume":"43","author":"F Antigny","year":"2008","unstructured":"Antigny F, Norez C, Becq F, Vandebrouck C. Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR. Cell Calcium. 2008;43:175\u201383.","journal-title":"Cell Calcium"},{"key":"3059_CR21","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1074\/jbc.M410617200","volume":"280","author":"CMP Ribeiro","year":"2005","unstructured":"Ribeiro CMP, Paradiso AM, Carew MA, Shears SB, Boucher RC. Cystic fibrosis Airway Epithelial Ca2\u2009+\u2009i signaling: THE MECHANISM FOR THE LARGER AGONIST-MEDIATED Ca2\u2009+\u2009i SIGNALS IN HUMAN CYSTIC FIBROSIS AIRWAY EPITHELIA *. J Biol Chem. 2005;280:10202\u20139.","journal-title":"J Biol Chem"},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"17798","DOI":"10.1074\/jbc.M410618200","volume":"280","author":"CMP Ribeiro","year":"2005","unstructured":"Ribeiro CMP, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, O\u2019Neal W, et al. Chronic Airway Infection\/Inflammation induces a Ca2\u2009+\u2009i-dependent Hyperinflammatory response in human cystic fibrosis Airway Epithelia *. J Biol Chem. 2005;280:17798\u2013806.","journal-title":"J Biol Chem"},{"key":"3059_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00126839-200607010-00002","volume":"7","author":"CMP Ribeiro","year":"2006","unstructured":"Ribeiro CMP. The role of intracellular calcium signals in inflammatory responses of polarised cystic Fibrosis Human Airway Epithelia. Drugs R D. 2006;7:17\u201331.","journal-title":"Drugs R D"},{"key":"3059_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.bbadis.2011.08.008","volume":"1812","author":"JR Martins","year":"2011","unstructured":"Martins JR, Kongsuphol P, Sammels E, Dahim\u00e8ne S, AlDehni F, Clarke LA, et al. F508del-CFTR increases intracellular Ca2+ signaling that causes enhanced calcium-dependent Cl\u2013 conductance in cystic fibrosis. Biochimica et Biophysica Acta (BBA) -. Mol Basis Disease. 2011;1812:1385\u201392.","journal-title":"Mol Basis Disease"},{"key":"3059_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jcf.2013.05.008","volume":"12","author":"L Vachel","year":"2013","unstructured":"Vachel L, Norez C, Becq F, Vandebrouck C. Effect of VX-770 (Ivacaftor) and OAG on Ca2\u2009+\u2009influx and CFTR activity in G551D and F508del-CFTR expressing cells. J Cyst Fibros. 2013;12:584\u201391.","journal-title":"J Cyst Fibros"},{"key":"3059_CR26","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1096\/fj.11-187682","volume":"25","author":"H Balghi","year":"2011","unstructured":"Balghi H, Robert R, Rappaz B, Zhang X, Wohlhuter-Haddad A, Evagelidis A, et al. Enhanced Ca2\u2009+\u2009entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways. FASEB J. 2011;25:4274\u201391.","journal-title":"FASEB J"},{"key":"3059_CR27","first-page":"892","volume":"1853","author":"R Philippe","year":"2015","unstructured":"Philippe R, Antigny F, Buscaglia P, Norez C, Becq F, Frieden M, et al. SERCA and PMCA pumps contribute to the deregulation of Ca2\u2009+\u2009homeostasis in human CF epithelial cells. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res. 2015;1853:892\u2013903.","journal-title":"Mol Cell Res"},{"key":"3059_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ceca.2019.05.007","volume":"81","author":"C Grebert","year":"2019","unstructured":"Grebert C, Becq F, Vandebrouck C. Focus on TRP channels in cystic fibrosis. Cell Calcium. 2019;81:29\u201337.","journal-title":"Cell Calcium"},{"key":"3059_CR29","doi-asserted-by":"crossref","unstructured":"Rimessi A, Vitto VAM, Patergnani S, Pinton P. Update on Calcium Signaling in Cystic Fibrosis Lung Disease. Frontiers in Pharmacology. 2021 [cited 2023 Apr 1];12. https:\/\/www.frontiersin.org\/articles\/","DOI":"10.3389\/fphar.2021.581645"},{"key":"3059_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nm0502-485","volume":"8","author":"ME Egan","year":"2002","unstructured":"Egan ME, Gl\u00f6ckner-Pagel J, Ambrose CA, Cahill PA, Pappoe L, Balamuth N, et al. Calcium-pump inhibitors induce functional surface expression of \u2206F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med. 2002;8:485\u201392.","journal-title":"Nat Med"},{"key":"3059_CR31","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1093941","volume":"304","author":"ME Egan","year":"2004","unstructured":"Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Gl\u00f6ckner-Pagel J, et al. Curcumin, a Major Constituent of Turmeric, corrects cystic fibrosis defects. Science. 2004;304:600\u20132.","journal-title":"Science"},{"key":"3059_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1600-0854.2006.00409.x","volume":"7","author":"C Norez","year":"2006","unstructured":"Norez C, Antigny F, Becq F, Vandebrouck C. Maintaining low Ca2\u2009+\u2009level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in Airway Epithelial cells. Traffic. 2006;7:562\u201373.","journal-title":"Traffic"},{"key":"3059_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.mito.2009.02.003","volume":"9","author":"F Antigny","year":"2009","unstructured":"Antigny F, Girardin N, Raveau D, Frieden M, Becq F, Vandebrouck C. Dysfunction of mitochondria Ca2\u2009+\u2009uptake in cystic fibrosis airway epithelial cells. Mitochondrion. 2009;9:232\u201341.","journal-title":"Mitochondrion"},{"key":"3059_CR34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/0024-3205(87)90510-8","volume":"40","author":"BL Shapiro","year":"1987","unstructured":"Shapiro BL, Lam LF. Intracellular calcium in cystic fibrosis heterozygotes. Life Sci. 1987;40:2361\u20136.","journal-title":"Life Sci"},{"key":"3059_CR35","first-page":"1872","volume":"12","author":"J Bargon","year":"1992","unstructured":"Bargon J, Trapnell BC, Chu CS, Rosenthal ER, Yoshimura K, Guggino WB, et al. Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations. Mol Cell Biol. 1992;12:1872\u20138.","journal-title":"Mol Cell Biol"},{"key":"3059_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ceca.2014.02.001","volume":"55","author":"RJ Lee","year":"2014","unstructured":"Lee RJ, Foskett JK. Ca2\u2009+\u2009signaling and fluid secretion by secretory cells of the airway epithelium. Cell Calcium. 2014;55:325\u201336.","journal-title":"Cell Calcium"},{"key":"3059_CR37","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.4049\/jimmunol.1800076","volume":"201","author":"FH Robledo-Avila","year":"2018","unstructured":"Robledo-Avila FH, Ruiz-Rosado J, de Brockman D, Kopp KL, Amer BT, McCoy AO. Dysregulated calcium homeostasis in cystic fibrosis neutrophils leads to deficient antimicrobial responses. J Immunol. 2018;201:2016\u201327.","journal-title":"J Immunol"},{"key":"3059_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00018-018-2989-3","volume":"76","author":"W Patel","year":"2019","unstructured":"Patel W, Moore PJ, Sassano MF, Lopes-Pacheco M, Aleksandrov AA, Amaral MD, et al. Increases in cytosolic Ca2\u2009+\u2009induce dynamin- and calcineurin-dependent internalisation of CFTR. Cell Mol Life Sci. 2019;76:977\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"3059_CR39","doi-asserted-by":"crossref","unstructured":"Antigny F, Norez C, Becq F, Vandebrouck C. CFTR and Ca2\u2009+\u2009Signaling in Cystic Fibrosis. Frontiers in Pharmacology. 2011 [cited 2022 Aug 4];2. https:\/\/www.frontiersin.org\/articles\/","DOI":"10.3389\/fphar.2011.00067"},{"key":"3059_CR40","doi-asserted-by":"publisher","first-page":"13729","DOI":"10.1038\/s41598-019-50066-7","volume":"9","author":"L Froux","year":"2019","unstructured":"Froux L, Coraux C, Sage E, Becq F. Short-term consequences of F508del-CFTR thermal instability on CFTR-dependent transepithelial currents in human airway epithelial cells. Sci Rep. 2019;9:13729.","journal-title":"Sci Rep"},{"key":"3059_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41598-018-36735-z","volume":"9","author":"RE Rayner","year":"2019","unstructured":"Rayner RE, Makena P, Prasad GL, Cormet-Boyaka E. Optimization of normal human bronchial epithelial (NHBE) cell 3D cultures for in vitro lung model studies. Sci Rep. 2019;9:500.","journal-title":"Sci Rep"},{"key":"3059_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1113\/jphysiol.2005.096669","volume":"569","author":"Z Bebok","year":"2005","unstructured":"Bebok Z, Collawn JF, Wakefield J, Parker W, Li Y, Varga K, et al. Failure of cAMP agonists to activate rescued \u2206F508 CFTR in CFBE41o\u2013 airway epithelial monolayers. J Physiol. 2005;569:601\u201315.","journal-title":"J Physiol"},{"key":"3059_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/352628a0","volume":"352","author":"JA Tabcharani","year":"1991","unstructured":"Tabcharani JA, Chang X-B, Riordan JR, Hanrahan JW. Phosphorylation-regulated CI\u2009\u2013\u2009channel in CHO cells stably expressing the cystic fibrosis gene. Nature. 1991;352:628\u201331.","journal-title":"Nature"},{"key":"3059_CR44","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","volume":"379","author":"D Keating","year":"2018","unstructured":"Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, et al. VX-445\u2013Tezacaftor\u2013ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. N Engl J Med. 2018;379:1612\u201320.","journal-title":"N Engl J Med"},{"key":"3059_CR45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/oxfordjournals.jbchem.a021780","volume":"122","author":"T Maruyama","year":"1997","unstructured":"Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of ins(1,4,5) P3-induced Ca2\u2009+\u2009release. J Biochem. 1997;122:498\u2013505.","journal-title":"J Biochem"},{"key":"3059_CR46","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1046\/j.1432-1033.2002.03060.x","volume":"269","author":"JG Bilmen","year":"2002","unstructured":"Bilmen JG, Wootton LL, Godfrey RE, Smart OS, Michelangeli F. Inhibition of SERCA Ca2\u2009+\u2009pumps by 2-aminoethoxydiphenyl borate (2-APB). 2-APB reduces both Ca2\u2009+\u2009binding and phosphoryl transfer from ATP, by interfering with the pathway leading to the Ca2+-binding sites. Eur J Biochem. 2002;269:3678\u201387.","journal-title":"Eur J Biochem"},{"key":"3059_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","volume":"185","author":"K Fiedorczuk","year":"2022","unstructured":"Fiedorczuk K, Chen J. Mechanism of CFTR correction by type I folding correctors. Cell. 2022;185:158\u2013e16811.","journal-title":"Cell"},{"key":"3059_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tcb.2018.01.002","volume":"28","author":"C Giorgi","year":"2018","unstructured":"Giorgi C, Danese A, Missiroli S, Patergnani S, Pinton P. Calcium Dynamics as a machine for decoding signals. Trends Cell Biol. 2018;28:258\u201373.","journal-title":"Trends Cell Biol"},{"key":"3059_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/ATVBAHA.123.318339","volume":"44","author":"A Jairaman","year":"2024","unstructured":"Jairaman A, Prakriya M, Arteriosclerosis. Thromb Vascular Biology. 2024;44:772\u201383.","journal-title":"Thromb Vascular Biology"},{"key":"3059_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceca.2017.05.003","volume":"69","author":"S Marchi","year":"2018","unstructured":"Marchi S, Patergnani S, Missiroli S, Morciano G, Rimessi A, Wieckowski MR, et al. Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium. 2018;69:62\u201372.","journal-title":"Cell Calcium"},{"key":"3059_CR51","doi-asserted-by":"publisher","first-page":"20849","DOI":"10.1074\/jbc.R116.735894","volume":"291","author":"E Carafoli","year":"2016","unstructured":"Carafoli E, Krebs J. Why Calcium? How Calcium became the best Communicator *. J Biol Chem. 2016;291:20849\u201357.","journal-title":"J Biol Chem"},{"key":"3059_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1513\/pats.201001-017AW","volume":"7","author":"CMP Ribeiro","year":"2010","unstructured":"Ribeiro CMP, Boucher RC. Role of endoplasmic reticulum stress in cystic fibrosis\u2013related airway inflammatory responses. Proc Am Thorac Soc. 2010;7:387\u201394.","journal-title":"Proc Am Thorac Soc"},{"key":"3059_CR53","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3389\/fphys.2018.01585","volume":"9","author":"T Mad\u00e1csy","year":"2018","unstructured":"Mad\u00e1csy T, Pallagi P, Maleth J. Cystic fibrosis of the pancreas: the role of CFTR Channel in the regulation of intracellular Ca2\u2009+\u2009signaling and mitochondrial function in the exocrine pancreas. Front Physiol. 2018;9:1585.","journal-title":"Front Physiol"},{"key":"3059_CR54","doi-asserted-by":"crossref","unstructured":"Zhong W, Darmani NA, Zhong W, Darmani NA. Role of Calcium in Vomiting. Calcium and Signal Transduction. IntechOpen; 2018 [cited 2024 Mar 26]. https:\/\/www.intechopen.com\/chapters\/61852","DOI":"10.5772\/intechopen.78370"},{"key":"3059_CR55","unstructured":"Zaher A, ElSaygh J, Elsori D, ElSaygh H, Sanni A. A review of Trikafta: triple cystic fibrosis transmembrane Conductance Regulator (CFTR) modulator therapy. Cureus 13:e16144."},{"key":"3059_CR56","unstructured":"Ciobanu DZ, Liessi N, Tomati V, Capurro V, Bertozzi SM, Summa M et al. Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS). Journal of Cystic Fibrosis. 2024 [cited 2024 Nov 16];0. https:\/\/www.cysticfibrosisjournal.com\/article\/S1569-1993(24)00067-5\/fulltext"},{"key":"3059_CR57","doi-asserted-by":"publisher","first-page":"00127","DOI":"10.1183\/23120541.00127-2017","volume":"4","author":"EK Schneider","year":"2018","unstructured":"Schneider EK, McQuade RM, Carbone VC, Reyes-Ortega F, Wilson JW, Button B, et al. The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites. ERJ Open Res. 2018;4:00127.","journal-title":"ERJ Open Res"},{"key":"3059_CR58","doi-asserted-by":"publisher","first-page":"e176328","DOI":"10.1172\/JCI176328","volume":"134","author":"A Kolski-Andreaco","year":"2024","unstructured":"Kolski-Andreaco A, Taiclet S, Myerburg MM, Sembrat J, Bridges RJ, Straub AC, et al. Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121. J Clin Investig. 2024;134:e176328.","journal-title":"J Clin Investig"},{"key":"3059_CR59","doi-asserted-by":"publisher","first-page":"e04083","DOI":"10.1128\/spectrum.04083-22","volume":"11","author":"C Cigana","year":"2023","unstructured":"Cigana C, Giannella R, Colavolpe A, Alcal\u00e1-Franco B, Mancini G, Colombi F, et al. Mutual effects of single and combined CFTR modulators and bacterial infection in cystic fibrosis. Microbiol Spectr. 2023;11:e04083.","journal-title":"Microbiol Spectr"},{"key":"3059_CR60","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.3390\/ijms251910360","volume":"25","author":"F Scial\u00f2","year":"2024","unstructured":"Scial\u00f2 F, Cernera G, Polise L, Castaldo G, Amato F, Villella VR. Effect of CFTR modulators on oxidative stress and autophagy in Non-CFTR-Expressing cells. Int J Mol Sci. 2024;25:10360.","journal-title":"Int J Mol Sci"},{"key":"3059_CR61","first-page":"11169","volume":"8","author":"M Rafeey","year":"2020","unstructured":"Rafeey M, Nikniaz Z, FarshiRadvar F, Sameni Z, Faramarzi E. Effects of Curcumin supplementation on quality of life of cystic fibrosis patients. Int J Pediatr. 2020;8:11169\u201376.","journal-title":"Int J Pediatr"},{"key":"3059_CR62","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13063-021-05224-6","volume":"22","author":"S Talebi","year":"2021","unstructured":"Talebi S, Safarian M, Jaafari MR, Sayedi SJ, Abbasi Z, Ranjbar G, et al. The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial. Trials. 2021;22:292.","journal-title":"Trials"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-03059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:03:12Z","timestamp":1734638592000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-03059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-03059-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}